STRATA Skin Sciences Inc. (SSKN)
2.62
-0.03 (-1.13%)
At close: Apr 08, 2025, 3:56 PM
2.73
4.20%
Pre-market: Apr 09, 2025, 04:11 AM EDT
STRATA Skin Sciences Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Sep 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dermatology Procedures Equipment Revenue | 3.42M | 3.1M | 2.06M | 3.1M | 3.57M | 2.79M | 2.36M | 4.07M | 3.57M | 3.52M | 1.97M | 2.37M | 6M | 1.93M | 1.15M | 1.64M | 1.78M | 1.11M | 714K | 2.33M | 1.49M | 1.89M | 2.17M | 2.37M | 1.31M | 3.01M | 1.75M | 2.5M | 1.54M | 1.89M | 1.55M | 1.63M | 1.99M | 1.19M |
| Dermatology Procedures Equipment Revenue Growth | +10.34% | +50.44% | -33.70% | -13.10% | +27.85% | +18.49% | -42.11% | +14.22% | +1.22% | +78.47% | -16.71% | -60.52% | +211.04% | +68.12% | -30.00% | -7.76% | +60.32% | +55.32% | -69.32% | +56.28% | -21.05% | -13.13% | -8.24% | +80.47% | -56.42% | +71.79% | -29.85% | +62.39% | -18.72% | +22.00% | -5.14% | -17.89% | +67.37% | n/a |
| Dermatology Recurring Procedures Revenue | 5.38M | 5.34M | 4.7M | 5.58M | 5.28M | 5.46M | 5.21M | 6.53M | 5.85M | 5.58M | 5.07M | 6.69M | 17.13M | 5.45M | 4.68M | 5.08M | 3.83M | 126K | 104K | 6.57M | 5.99M | 5.84M | 5.31M | 5.17M | n/a | 4.99M | 5.72M | 6.2M | 5.73M | 6.73M | 6.21M | 6.09M | 5.53M | 7.03M |
| Dermatology Recurring Procedures Revenue Growth | +0.79% | +13.69% | -15.92% | +5.78% | -3.23% | +4.74% | -20.22% | +11.66% | +4.75% | +10.16% | -24.23% | -60.96% | +214.20% | +16.52% | -7.84% | +32.39% | +2943.65% | +21.15% | -98.42% | +9.68% | +2.60% | +9.92% | +2.81% | n/a | -100.00% | -12.81% | -7.77% | +8.22% | -14.87% | +8.49% | +1.84% | +10.22% | -21.40% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|
| China Revenue | 3.34M | 4.75M | 23.2M | 26.18M | 25.54M | 14.72M |
| China Revenue Growth | -29.70% | -79.52% | -11.39% | +2.51% | +73.43% | n/a |
| Domestic Revenue | 23.03M | 23.98M | n/a | n/a | n/a | n/a |
| Domestic Revenue Growth | -3.97% | n/a | n/a | n/a | n/a | n/a |
| Korea Revenue | 2.73M | 3.72M | n/a | n/a | n/a | n/a |
| Korea Revenue Growth | -26.59% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 6.72M | 5.22M | 5.73M | 5.58M | 5.32M | 5.91M | 6.66M | 6.27M | 6.37M | 6.48M | 6.27M | 17.35M | 5.47M | 5.28M | 5.72M | 4.57M | 3.98M | 3.33M | 5.05M | 5.97M | 5.11M | 5.66M | 5.55M | 5.35M | 4.67M | 4.71M | 4.67M | 4.74M | 4.37M | 4.8M | 4.75M | 4.83M | 4.72M | 5.42M | 5.81M | 6.42M | 7.13M | 2.86M | 2.76M |
| Selling, General, and Administrative Revenue Growth | +28.58% | -8.80% | +2.69% | +4.83% | -9.91% | -11.31% | +6.15% | -1.51% | -1.68% | +3.35% | -63.87% | +217.15% | +3.58% | -7.69% | +25.21% | +14.80% | +19.45% | -34.09% | -15.31% | +16.92% | -9.77% | +2.02% | +3.59% | +14.62% | -0.85% | +0.79% | -1.33% | +8.52% | -9.01% | +0.97% | -1.72% | +2.42% | -12.98% | -6.66% | -9.47% | -10.01% | +149.41% | +3.51% | n/a |
| Research and Development Revenue | 243K | 199K | 241K | 380K | 248K | 374K | 315K | 441K | 216K | 209K | 163K | 1.06M | 371K | 403K | 384K | 324K | 411K | 247K | 292K | 214K | 249K | 235K | 304K | 234K | 224K | 269K | 338K | 402K | 411K | 423K | 475K | 388K | 382K | 634K | 525K | 1.08M | 471K | 282K | 238.87K |
| Research and Development Revenue Growth | +22.11% | -17.43% | -36.58% | +53.23% | -33.69% | +18.73% | -28.57% | +104.17% | +3.35% | +28.22% | -84.67% | +186.52% | -7.94% | +4.95% | +18.52% | -21.17% | +66.40% | -15.41% | +36.45% | -14.06% | +5.96% | -22.70% | +29.91% | +4.46% | -16.73% | -20.41% | -15.92% | -2.19% | -2.84% | -10.95% | +22.42% | +1.57% | -39.75% | +20.76% | -51.52% | +129.94% | +67.02% | +18.05% | n/a |
| Sales and Marketing Revenue | 3.05M | 3.01M | 3.02M | 2.76M | 3.04M | 3.42M | 3.74M | 3.79M | 3.75M | 4.15M | 3.62M | 9.81M | 3.29M | 3.16M | 2.93M | 2.59M | 2.05M | 1.44M | 2.95M | 3.09M | 2.89M | 2.96M | 3.07M | 2.89M | 2.49M | 2.38M | 2.87M | 2.33M | 2.69M | 3.08M | 3.15M | 3.08M | 2.84M | 3.52M | 3.71M | 3.21M | 4M | 910K | 1.03M |
| Sales and Marketing Revenue Growth | +1.13% | -0.13% | +9.35% | -9.15% | -11.07% | -8.71% | -1.14% | +0.83% | -9.45% | +14.66% | -63.14% | +197.75% | +4.27% | +7.78% | +13.12% | +26.38% | +42.23% | -51.17% | -4.50% | +7.10% | -2.40% | -3.52% | +6.20% | +16.08% | +4.58% | -17.17% | +22.96% | -13.10% | -12.67% | -2.32% | +2.31% | +8.42% | -19.39% | -5.04% | +15.58% | -19.77% | +339.67% | -11.39% | n/a |